Notice of Refund | Mar 14, 2019 | PAPER | BOARD |
Refund Request of Post Institution Fees | Feb 6, 2019 | PAPER | PETITIONER |
DECISION
Denying Institution of Inter Partes Review
35 U.S.C. § 314 | Jan 16, 2019 | PAPER | BOARD |
U.S. Patent No. 5,969,040, issued October 19, 1999 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 6,037,452, issued March 14, 2000 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 6,686,179, issued February 3, 2004 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent Publication No. 2003/0199043, published October 23, 2003 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent Publication No. 2005/0032174, published February 10, 2005 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Declaration of John Pasi, M.B. Ch.B., Ph.D., October 23, 2018 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Excerpts of File History for U.S. Patent No. 9,623,091 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 7,592,010, issued September 22, 2009 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2002/040544, published May 23, 2002 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2007/115724, published October 18, 2007 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2007/149406, published December 27, 2007 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2008/118507, published October 2, 2008 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2009/051717, published April 23, 2009 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2009/130198, published October 29, 2009 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2003/020764, published March 13, 2003 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2004/101740, published November 25, 2004 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2006/074199, published July 13, 2006 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2009/137254, published November 12, 2009 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2009/140015, published November 19, 2009 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2012/006624, Published January 1, 2012 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Prescribing Information for Alprolix¿¿ (Revised: 06/2018) (Alprolix Label) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Andersen and Sandlie, The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostic and Therapeutics, Drug Metab. Pharmacokinet. 24(4): 318-332, 321 (2009) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Chaudhury et al., Albumin Binding to FcRn: Distinct from the FcRn-IgG Interaction, Biochemistry 45, 4983¿¿¿90 (2006) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Choo et al., Molecular cloning of the gene for human anti-haemophilic Factor IX, Nature 299, 178¿¿¿80 (1982) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Fischer, K., et al., Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors, Haemophilia, 14(Suppl. 3): 196-201 (2008) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Kaufman et al., Expression, Purification, and Characterization of Recombinant ¿¿-Carboxylated Factor IX Synthesized in Chinese Hamster Ovary Cells, The Journal of Biological Chemistry 261(21) 9622¿¿¿28 (1986) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Manco-Johnson MJ, et al., Advances in care of children with hemophilia, Semin Thromb Hemost. 29(6) 585-594 (2003) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Manco-Johnson MJ, et al., Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia, The New England Journal of Medicine 357:6; 535-544 (2007) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Andersen et al., Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding, The Journal of Biological Chemistry 285(7):4826-4836 (2010) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
BeneFix Circular (Benefix Label) Dated November 16, 2004 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Berntrop, Consensus perspectives on prophylactic therapy for haemophilia: summary statement, Haemophilia 9(Suppl. 1):1-4 (2003) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Chaudhury et al., The Major Histocompatibility Complex-related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan, J. Exp. Med. 197(3), 315¿¿¿22 (2003) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Ducore et al., Alprolix (recombinant factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B, 7(5) Expert Rev. Hematology 559 (2014) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Fischer, K., et al., Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors, Haemophilia, 14(Suppl. 3): 196-201 (2008) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Joint Claim Construction Worksheet filed on September 13, 2018 in Bioverativ Inc. et al. v. CSL Behring LLC et al., CA. No. 17-914 (GMS), dated September 13, 2018. | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Levin et al., Lost in Translation, Bumps in the Road Between Bench and Bedside, JAMA 303(15) 1533-1534 (2010) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Petrini, P., What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia, Haemophilia 7, 99-102 (2001) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Schmidt and Bajaj, Structure-Function Relationships in Factor IX and Factor IXa, Trends in Cardiovascular Medicine 13(1) 39¿¿¿45 (2003) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Yoshitake et al., Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B), Biochemistry 24(14), 3736¿¿¿50 (1985) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Ober et al., Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies, International Immunology 13(12): 1551-1559 (2001) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Proetzel and Roopenian, Humanized FcRn Mouse Models for Evaluating Pharmacokinetics of human IgG Antibodies, Methods 65(1): 148-153 (2014) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Roopenian and Akilesh FcRn: the neonatal Fc receptor comes of age, Nature Review Immunology 7, 715¿¿¿25 (2007) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
E. Santagostino, Prophylaxis in haemophilia B patients: unresolved issues and pharmacoeconomic implications, Haemophilia 16 (Suppl. 6), 13-17 (2010) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Schafer and Kolkhof, Failure is an option: learning from unsuccessful proof-of-concept trials, Drug Discovery Today 13, 913-916 (2008) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Zhang et al., Population pharmacokinetics of a new long-acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B, Journal of Thrombosis and Haemostasis 14: 2132-2140 (2016) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Declaration of John Pasi, M.B. Ch.B., Ph.D., October 23, 2018 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 7,592,010, issued September 22, 2009 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent Publication No. 2003/0199043, published October 23, 2003 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2003/020764, published March 13, 2003 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner's Preliminary Response | Oct 23, 2018 | PAPER | PATENT OWNER |
Declaration of Allen R. Rines, October 23, 2018 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Declaration of Brendan T. Jones, October 23, 2018 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Excerpts of File History for U.S. Patent No. 9,623,091 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 5,969,040, issued October 19, 1999 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 6,037,452, issued March 14, 2000 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 6,686,179, issued February 3, 2004 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent Publication No. 2005/0032174, published February 10, 2005 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
WO 2002/040544, published May 23, 2002 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Notice of Accord Filing Date | Jul 23, 2018 | PAPER | BOARD |
IPR 2018-01345 Patent Owner Mandatory Notice | Jul 23, 2018 | PAPER | PATENT OWNER |
IPR 2018-01345 Patent Owner Power of Attorney | Jul 23, 2018 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notice | Jul 19, 2018 | PAPER | PETITIONER |
Petitioners' Amended Power of Attorney | Jul 19, 2018 | PAPER | PETITIONER |
US 7404956 | Jul 6, 2018 | EXHIBIT | PETITIONER |
US App 11043569 | Jul 6, 2018 | EXHIBIT | PETITIONER |
US App 15043455 | Jul 6, 2018 | EXHIBIT | PETITIONER |
USP 61363064 | Jul 6, 2018 | EXHIBIT | PETITIONER |
USP 61430819 | Jul 6, 2018 | EXHIBIT | PETITIONER |
Amevive | Jul 6, 2018 | EXHIBIT | PETITIONER |
Bjorkman | Jul 6, 2018 | EXHIBIT | PETITIONER |
Enbrel | Jul 6, 2018 | EXHIBIT | PETITIONER |
Key | Jul 6, 2018 | EXHIBIT | PETITIONER |
MASAC | Jul 6, 2018 | EXHIBIT | PETITIONER |
McGraw | Jul 6, 2018 | EXHIBIT | PETITIONER |
Monahan | Jul 6, 2018 | EXHIBIT | PETITIONER |
Nilsson | Jul 6, 2018 | EXHIBIT | PETITIONER |
Steen-Carlsson | Jul 6, 2018 | EXHIBIT | PETITIONER |
Power of Attorney | Jul 6, 2018 | PAPER | PETITIONER |
US 9623091 | Jul 6, 2018 | EXHIBIT | PETITIONER |
US 20080260755 | Jul 6, 2018 | EXHIBIT | PETITIONER |
USP 61442079 | Jul 6, 2018 | EXHIBIT | PETITIONER |
USP 61438572 | Jul 6, 2018 | EXHIBIT | PETITIONER |
USP 61424555 | Jul 6, 2018 | EXHIBIT | PETITIONER |
USP 61470951 | Jul 6, 2018 | EXHIBIT | PETITIONER |
455 Final OA | Jul 6, 2018 | EXHIBIT | PETITIONER |
455 Notice of Allowability | Jul 6, 2018 | EXHIBIT | PETITIONER |
Anderson | Jul 6, 2018 | EXHIBIT | PETITIONER |
Alprolix | Jul 6, 2018 | EXHIBIT | PETITIONER |
Baggio | Jul 6, 2018 | EXHIBIT | PETITIONER |
Lorenzo | Jul 6, 2018 | EXHIBIT | PETITIONER |
Carlsson | Jul 6, 2018 | EXHIBIT | PETITIONER |
Coppola | Jul 6, 2018 | EXHIBIT | PETITIONER |
Fischer | Jul 6, 2018 | EXHIBIT | PETITIONER |
Claim Construction Chart | Jul 6, 2018 | EXHIBIT | PETITIONER |
Fischer 2003 | Jul 6, 2018 | EXHIBIT | PETITIONER |
Idelvion | Jul 6, 2018 | EXHIBIT | PETITIONER |
Metzner | Jul 6, 2018 | EXHIBIT | PETITIONER |
Muller | Jul 6, 2018 | EXHIBIT | PETITIONER |
Pechtner | Jul 6, 2018 | EXHIBIT | PETITIONER |
Petrini | Jul 6, 2018 | EXHIBIT | PETITIONER |
Peters 2010 | Jul 6, 2018 | EXHIBIT | PETITIONER |
World Proceedings | Jul 6, 2018 | EXHIBIT | PETITIONER |
Quinlan | Jul 6, 2018 | EXHIBIT | PETITIONER |
Roth | Jul 6, 2018 | EXHIBIT | PETITIONER |
Saenko | Jul 6, 2018 | EXHIBIT | PETITIONER |
Schroeder | Jul 6, 2018 | EXHIBIT | PETITIONER |
Schulte | Jul 6, 2018 | EXHIBIT | PETITIONER |
Shapiro | Jul 6, 2018 | EXHIBIT | PETITIONER |
Sockolosky | Jul 6, 2018 | EXHIBIT | PETITIONER |
van Dijk | Jul 6, 2018 | EXHIBIT | PETITIONER |
Hacker | Jul 6, 2018 | EXHIBIT | PETITIONER |
Santagostino | Jul 6, 2018 | EXHIBIT | PETITIONER |
Peters Abstract 2007 | Jul 6, 2018 | EXHIBIT | PETITIONER |
PTE Letter for US 8329182 | Jul 6, 2018 | EXHIBIT | PETITIONER |
455 Amd and Reply | Jul 6, 2018 | EXHIBIT | PETITIONER |
Crisafulli Declaration | Jul 6, 2018 | EXHIBIT | PETITIONER |
Peters 1.132 Declaration | Jul 6, 2018 | EXHIBIT | PETITIONER |
Maher Declaration | Jul 6, 2018 | EXHIBIT | PETITIONER |
IDS from prosecution history | Jul 6, 2018 | EXHIBIT | PETITIONER |
Fee Authorization | Jul 6, 2018 | PAPER | PETITIONER |
Hall-Ellis Declaration | Jul 6, 2018 | EXHIBIT | PETITIONER |
Initial Petition | Jul 6, 2018 | PAPER | PETITIONER |
Negrier Declaration | Jul 6, 2018 | EXHIBIT | PETITIONER |